Omega-3 Fatty Acids, Docosahexaenoic Acid and Eicosapentaenoic Acid: study protocols
5 study groups took Omega-3 Fatty Acids together with Docosahexaenoic Acid and Eicosapentaenoic Acid. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Omega-3 Fatty Acids
5 study groups in 5 studies say how much Omega-3 Fatty Acids participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g and 2.5 g to 5 g, 40% of 5 study groups each.
| Daily dose | Study groups |
|---|---|
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 2 |
| 2.5 g to 5 g | 2 |
Dose per serving from research: Docosahexaenoic Acid
5 study groups in 5 studies say how much Docosahexaenoic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg and 1 g to 2.5 g, 40% of 5 study groups each.
| Daily dose | Study groups |
|---|---|
| 100 mg to 250 mg | 2 |
| 250 mg to 500 mg | 0 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 2 |
Dose per serving from research: Eicosapentaenoic Acid
5 study groups in 5 studies say how much Eicosapentaenoic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 40% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 50 mg or less | 1 |
| 50 mg to 100 mg | 0 |
| 100 mg to 250 mg | 0 |
| 250 mg to 500 mg | 1 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 2 |
Commonly used together
2 of 5 study groups took Omega-3 Fatty Acids, Docosahexaenoic Acid and Eicosapentaenoic Acid with something else, but nothing that 3 or more different studies gave.
5 study groups
| Study | |||||
|---|---|---|---|---|---|
| Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study 2007 · omega-3 fatty acids · Children aged 5 to 17 years with autistic disorders accompanied by severe tantrums, aggression, or self-injurious behavior | 1.5 g | 700 mg | 840 mg | 6 weeks | — |
| Effects of a Long Chain n-3 Polyunsaturated Fatty Acid-rich Multi-ingredient Nutrition Supplement on Body Composition and Physical Function in Older Adults with Low Skeletal Muscle Mass 2022 · supplement (SUPP) · Community-dwelling older adults with low skeletal muscle mass; mean age 74.9 years; 18 men and 19 women in the study overall | 3 g | 1.5 g | 1.5 g | 26 weeks | — |
| Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study 2002 · group 2 (Maxigard group) · Adults with type 2 diabetes and BMI <27 kg/m²; age and sex not specified | 1.2 g | 240 mg | 360 mg | 6 weeks | 25 |
| The influence of low intake of n-3 fatty acids on platelets in elderly people 1999 · n-3 PUFA group · healthy elderly people; age range and sex not stated | 600 mg | 150 mg | 30 mg | 6 weeks | 10 |
| The immunomodulatory effects of fish-oil supplementation in elite paddlers: A pilot randomized double blind placebo-controlled trial 2015 · fish-oil capsules · male elite paddlers undertaking an increasing exercise program | 3.6 g | 1.2 g | 2.4 g | 4 weeks | 11 |